CiteULike: guhjy's Miskulin:D [6 articles]

Key Comorbid Conditions that Are Predictive of Survival among Hemodialysis Patients.

Clinical journal of the American Society of Nephrology : CJASN (24 September 2009)

by Dana Miskulin, Jennifer Bragg-Gresham, Brenda W. Gillespie, et al.Francesca Tentori, Ronald L. Pisoni, Hocine Tighiouart, Andrew S. Levey, Friedrich K. Port

posted to mortality hd dopps by guhjy on 2009-10-10 02:27:38 as

Disordered Mineral Metabolism in Hemodialysis Patients: An Analysis of Cumulative Effects in the Hemodialysis (HEMO) Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation (25 July 2008)

by Ron Wald, Mark J J. Sarnak, Hocine Tighiouart, et al.Alfred K K. Cheung, Andrew S S. Levey, Garabed Eknoyan, Dana C C. Miskulin

posted to ca hd hemo p rct by guhjy on 2008-08-06 07:36:13 as

Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial

Kidney Int, Vol. 60, No. 4. (October 2001), pp. 1498-1510.

by Dana C. Miskulin, Nicolaos V. Athienites, Guofen Yan, et al.Alice A. Martin, Daniel B. Ornt, John W. Kusek, Klemens B. Meyer, Andrew S. Levey

posted to comorbidity hd rct by guhjy on 2008-07-08 04:26:27 as

Imperial or empirical measures of dialysis quality?

American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 50, No. 5. (November 2007), pp. 691-695.

by K. B. Meyer, D. C. Miskulin

posted to no-tag by guhjy on 2008-04-18 05:45:18 as

Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network.

Am J Kidney Dis, Vol. 49, No. 2. (February 2007), pp. 257-266.

by R. Wald, F. Tentori, H. Tighiouart, P. G. Zager, D. C. Miskulin

posted to no-tag by guhjy on 2007-08-23 03:14:48 as

along with 1 person shekloke

Which Targets in Clinical Practice Guidelines Are Associated with Improved Survival in a Large Dialysis Organization?

J Am Soc Nephrol, Vol. 18, No. 8. (1 August 2007), pp. 2377-2384.

by Francesca Tentori, William C. Hunt, Mark Rohrscheib, et al.Min Zhu, Christine A. Stidley, Karen Servilla, Dana Miskulin, Klemens B. Meyer, Edward J. Bedrick, Keith H. Johnson, Philip G. Zager

posted to gdl mortality hd by guhjy on 2007-07-31 09:43:05 as

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

	Key Comorbid Conditions that Are Predictive of Survival among Hemodialysis Patients. [My Copy] Clinical journal of the American Society of Nephrology : CJASN (24 September 2009) by Dana Miskulin, Jennifer Bragg-Gresham, Brenda W. Gillespie, et al.Francesca Tentori, Ronald L. Pisoni, Hocine Tighiouart, Andrew S. Levey, Friedrich K. Port posted to mortality hd dopps by guhjy on 2009-10-10 02:27:38 as
	Disordered Mineral Metabolism in Hemodialysis Patients: An Analysis of Cumulative Effects in the Hemodialysis (HEMO) Study. [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation (25 July 2008) by Ron Wald, Mark J J. Sarnak, Hocine Tighiouart, et al.Alfred K K. Cheung, Andrew S S. Levey, Garabed Eknoyan, Dana C C. Miskulin posted to ca hd hemo p rct by guhjy on 2008-08-06 07:36:13 as
	Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial [My Copy] Kidney Int, Vol. 60, No. 4. (October 2001), pp. 1498-1510. by Dana C. Miskulin, Nicolaos V. Athienites, Guofen Yan, et al.Alice A. Martin, Daniel B. Ornt, John W. Kusek, Klemens B. Meyer, Andrew S. Levey posted to comorbidity hd rct by guhjy on 2008-07-08 04:26:27 as
	Imperial or empirical measures of dialysis quality? [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 50, No. 5. (November 2007), pp. 691-695. by K. B. Meyer, D. C. Miskulin posted to no-tag by guhjy on 2008-04-18 05:45:18 as
	Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network. [My Copy] Am J Kidney Dis, Vol. 49, No. 2. (February 2007), pp. 257-266. by R. Wald, F. Tentori, H. Tighiouart, P. G. Zager, D. C. Miskulin posted to no-tag by guhjy on 2007-08-23 03:14:48 as along with 1 person shekloke
	Which Targets in Clinical Practice Guidelines Are Associated with Improved Survival in a Large Dialysis Organization? [My Copy] J Am Soc Nephrol, Vol. 18, No. 8. (1 August 2007), pp. 2377-2384. by Francesca Tentori, William C. Hunt, Mark Rohrscheib, et al.Min Zhu, Christine A. Stidley, Karen Servilla, Dana Miskulin, Klemens B. Meyer, Edward J. Bedrick, Keith H. Johnson, Philip G. Zager posted to gdl mortality hd by guhjy on 2007-07-31 09:43:05 as

guhjy's Miskulin:D [6 articles] Export Sort

guhjy's tags

ckd	1742
rct	1206
dn	1176
dm	1073
cancer	1068
ma	981
cv	936
hd	859
tgfb	857
snp	773
ros	707
bp	645
kidney	532
meta-analysis	516
mouse	509
uae	501
stats	480
software	468
pt	458
genetics	450
mirna	450
proteomics	414
mortality	411
rat	402
1	391
fbl	386
inflammation	378
tw	378
mtor	364
proteinuria	356
pcr	356
mc	351
akt	351
method	340
db	337
acei	335
irs	333
gdl	332
inhibitor	329
test	325
apoptosis	321
urine	320
age	318
arb	318
aging	315
ms	314
aii	310
hcv	308
r	297
hg	293
biomarker	288
pi3k	284
ppi	282
bias	278
bayes	275
aki	272
gwa	271
emt	268
s6k	266
rnai	257
egfr	256
nutrition	255
ub	248
p53	246
fibrosis	242
erk	238
obesity	237
smad	234
cox	229
drug	225
pbmc	223
hcc	217
hypoxia	216
metab	215
gn	210
nfkb	209
herb	205
stz	199
collagen	197
albumin	189
lc	187
hif	187
pkc	181
longitudinal	179
pubmed	179
lmm	178
p38	176
gfr	175
ua	171
epigenetics	169
book	168
bioinf	167
japan	166
cea	163
power	163
gender	162
dna-damage	162
rage	162
lead	160
cadmium	159
genomics	156
ref	152
ctgf	150
vitamin-d	149
liver	147
stata	147
company	146
mt	146
network	146
diet	138
screening	137
rt	136
phosphorylation	135
insulin	135
seq	133
no	132
stat	129
kinase	128
go	128
cell-cycle	128
esrd	128
pathway	127
protein	127
systems-biology	124
statin	121
lipid	119
creatinine	117
proliferation	113
senescence	112
podocyte	111
imaging	110
gene-therapy	110
nox	109
mapk	109
tnf	107
hypertrophy	105
p21	104
fish	104
pparg	104
regression	103
cad	103
case-control	102
gfr-formula	102
pd	102
imputation	101
multiplicity	100
ampk	100
plasmid	98
observational	98
at1	98
sirt	97
ko	97
rx	96
methylation	96
pediatric	96
cloning	96
recurrent	94
betel	93
blood	93
src	93
review	92
chf	92
website	91
nhanes	91
immunity	89
anemia	89
phenotype	88
diagnosis	87
autophagy	87
lr	86
toxicology	86
epo	85
uti	85
ebm	84
cytokine	84
ca	83
p	83
china	83
environment	82
cachexia	81
nonp	81
oat	81
hapmap	80
gout	80
qms	78
primer	78
signaling	76
foxo	74
col4	74
promoter	74
egf	74
missing	73
gpcr	73
ace	73
eif	73
gene-list	72
surrogate	72
cox2	72
hts	72
lpd	72
4ebp	72
eqtl	72
stone	72
p-value	71
mv	71
jnk	70
metformin	70
mgo	70
phd	70
salt	70
glycemia	69
uuo	67
tin	67
normalization	66
fluorescence	66
uncertainty	66
enddysf	65
ifn	65
chinese	65
pe	65
mirna-target	65
translation	65
hsp	64
association	64
shc	64
pla2	64
llcpk1	63
acid-base	63
causation	63
2dge	63
yeast	63
pdgf	62
pai1	62
simulation	62
oglcnac	62
me	62
nrk49f	62
smoking	62
avf	61
mmp	61
confounding	61
vegf	61
ptm	61
crp	60
outcome	60
sas	60
melamine	60
change	60
pld	60
oral	60
cost	60
infection	60
hk2	60
alcohol	58
iron	58
rho	58
model-selection	57
rapamycin	57
urate-transporter	57
cyclin-d1	57
pls	57
robust	57
achr	56
aceiarb	56
calibration	56
semantic	56
ratio	55
competing-risk	55
ncrna	55
estrogen	55
ace2	55
stem-cell	55
goldstd	55
function	54
workflow	54
bone	54
ckd-progression	54
k	53
dipstick	53
std	53
p27	53
renoprotection	53
hsc	53
il6	53
tf	52
histone	52
qc	52
atm	52
dimerization	52
hdac	52
fgf	52
lod	51
epidemiology	51
normoalbuminuria	51
hepatocyte	51
ab	51
pth	51
matlab	50
wnt	50
graph	50
risk-ratio	50
adpkd	50
arsenic	50
reasoning	50
mercury	50
biosensor	49
pdk	49
epistasis	49
antibiotics	49
klotho	49
gene-environment	49
ffpe	48
ukm	48
core-curriculum	48
nrk52e	48
ngal	48
endothelium	48
irs1	48
breakpoint	48
ras	47
enos	47
spot-urine	47
mtorc1	47
pooling	47
aldosterone	47
joint-model	47
hgf	46
dub	46
aspirin	46
fdr	46
er-stress	46
metal	46
cystatin	46
protein-microarray	46
prevention	45
semip	45
ecm	45
fgf23	45
writing	45
tgfbr	45
dbdb	45
cnv	44
ccb	44
mesangial	44
diuretics	44
variability	44
sumo	44
interaction	44
ancova	44
sle	43
bia	43
klf	43
na	43
design	43
good	42
fibronectin	42
icu	42
roc	42
catenin	42
asia	42
stroke	42
vsmc	42
agreement	42
bmi	42
proteasome	41
fuzzy	41
gene-targeting	41
qtl	41
hyperfiltration	40
alignment	40
ap1	40
sage	40
tlr	40
wga	40
tea	40
rca	40
risk	40
omics	39
coffee	39
antisense	39
igf	39
rsk	39
protein-complex	39
glut	39
urinalysis	39
dry-bw	39
angiogenesis	39
mtorc2	38
gsk3	38
igan	38
emr	38
myc	38
snx	38
rvh	38
adenosine	37
propensity	37
haplotype	37
gsk	37
fabp	37
megalin	37
bh4	37
adh	37
hematuria	37
exercise	36
animal	36
il1	36
inflammasome	36
web20	36
nephrotoxicity	36
s100b	36
cardiorenal	36
pka	35
threshold	35
chemogenomics	35
creb	35
reverse-epidemiology	35
adduct	35
subgroup	35
cre	35
calcification	35
sp1	35
annotation	35
sglt	35
candidate-gene	35
igf1	34
sepsis	34
attrition	34
pp2a	34
effect-size	34
cross-species	34
msm	34
pathology	34
bmp	33
rtk	33
et	33
cage	33
ns	33
ecology	33
sarcopenia	33
zeb	33
browser	33
integrin	33
set	32
steroid	32
orbitrap	32
text-mining	32
zfn	32
fc	32
transactivation	32
aa	32
macrophage	32
addgene	32
ai	32
affy	32
end-point	32
gsh	31
hospitalization	31
acidosis	31
cr	31
family	31
silac	31
heritability	31
reporter	31
gllamm	31
nutrient	31
abp	31
risk-difference	31
agt	31
frailty	31
emsa	31
blast	31
carcinogen	30
staging	30
mw	30
s100	30
transporter	30
pten	30
notch	30
human	30
grn	30
membrane-protein	30
knockout	30
geo	30
perindopril	29
validation	29
thesis	29
virus	29
ub-ligase	29
renin	29
nicotinic	29
extraction	29
sgk	29
3	29
pharmacogenetics	28
time-dependent	28
jun	28
muscarinic	28
hplc	28
gee	28